Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Global Cryoablation for Cancer Market Research Report 2025

Global Cryoablation for Cancer Market Research Report 2025

Industry: Medical Devices & Consumables

Published: 2025-01-13

Pages: 87 Pages

Report ld: 3491680

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Cryoablation for Cancer was valued at US$ 1136 million in the year 2024 and is projected to reach a revised size of US$ 1580 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Cryoablation is a novel treatment currently used to treat benign breast tumors (called fibroadenomas). Cryoablation is now being studied in patients with certain types of small breast cancer. The treatment places a small probe in the center of the cancer and subsequently uses liquid nitrogen to destroy breast cancer tumors by freezing them.In the treatment of fibroadenomas, cryoablation has proven less invasive and less likely to affect cosmetic appearance than surgery. It could be possible for breast cancer patients to enjoy the same benefits in the future.

Cryoablation for Cancer Market Size(US$)

M= millions and B=billions

The global cryoablation for cancer market refers to the market for medical devices and procedures that use cryoablation technology to treat cancer. Cryoablation is a minimally invasive technique that uses extreme cold temperatures to destroy cancer cells, primarily through freezing them.

Here are some key factors driving the growth of the global cryoablation for cancer market:
Increasing cancer prevalence: The global incidence of cancer continues to rise, creating a significant demand for effective and less invasive treatment options. Cryoablation offers advantages such as minimal damage to surrounding healthy tissues, shorter recovery times, and reduced complications, making it an attractive treatment option for both patients and healthcare providers.

Growing adoption of minimally invasive procedures: Minimally invasive techniques are gaining popularity in the field of cancer treatment due to their benefits over traditional open surgeries. Cryoablation is a minimally invasive procedure that can be performed with smaller incisions, leading to reduced post-operative pain, shorter hospital stays, and quicker recovery compared to traditional surgery.

Technological advancements: The development of advanced cryoablation systems and devices with improved efficiency and precision is driving market growth. These advancements enable more targeted and controlled freezing of cancerous tissues, resulting in higher success rates and better patient outcomes. Integration of imaging technologies, such as ultrasound or MRI, with cryoablation systems further enhances the effectiveness of the procedure.

Rising demand for outpatient procedures: With the shift towards less invasive and outpatient procedures, cryoablation for cancer treatment is gaining traction. Cryoablation can often be performed on an outpatient basis, allowing patients to return home on the same day, reducing healthcare costs, and improving patient convenience.

Increasing investments in research and development: Pharmaceutical and medical device companies, as well as research institutions, are investing in the development of advanced cryoablation technologies and techniques. This investment aims to improve treatment efficacy, expand the range of treatable cancers, and reduce potential side effects, further driving market growth.

Favorable reimbursement policies: The availability of favorable reimbursement policies for cryoablation procedures, especially in developed markets, is contributing to increased adoption. Reimbursement support makes cryoablation more accessible and affordable for patients, thereby boosting market growth.

In conclusion, the global cryoablation for cancer market is driven by factors such as the increasing prevalence of cancer, growing adoption of minimally invasive procedures, technological advancements, rising demand for outpatient treatments, investments in research and development, and favorable reimbursement policies. The market is expected to grow as cryoablation continues to evolve as an effective and less invasive option for cancer treatment, providing improved patient outcomes and quality of life.

This report aims to provide a comprehensive presentation of the global market for Cryoablation for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cryoablation for Cancer.

The Cryoablation for Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cryoablation for Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cryoablation for Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Cryoablation for Cancer Market Research Report 2025
Forecasted Market Size in 2031
US$ 1580 million
CAGR(2025-2031)
4.9%
Market Size Available for Years
2025-2031
Global Cryoablation for Cancer Companies Covered
BTG International Ltd
IceCure Medical
Adagio Medical
CooperSurgical
HOYA
Medtronic
Boston Scientific
Sanarus Technologies
AtriCure
Cryofocus Biotech
Endo International Plc
Global Cryoablation for Cancer Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cryoablation for Cancer Market, Segment by Type
Cryoablation System
Cyroablation Needles
Cyroprobes
Others
Global Cryoablation for Cancer Market, Segment by Application
Hospitals
Specialty Clinics
Outpatient Surgery Center
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cryoablation for Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cryoablation for Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
        1.2.2 Cryoablation System
        1.2.3 Cyroablation Needles
        1.2.4 Cyroprobes
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Cryoablation for Cancer Market Growth by Application: 2020 VS 2024 VS 2031
        1.3.2 Hospitals
        1.3.3 Specialty Clinics
        1.3.4 Outpatient Surgery Center
        1.3.5 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Cryoablation for Cancer Market Perspective (2020-2031)
    2.2 Global Cryoablation for Cancer Growth Trends by Region
        2.2.1 Global Cryoablation for Cancer Market Size by Region: 2020 VS 2024 VS 2031
        2.2.2 Cryoablation for Cancer Historic Market Size by Region (2020-2025)
        2.2.3 Cryoablation for Cancer Forecasted Market Size by Region (2026-2031)
    2.3 Cryoablation for Cancer Market Dynamics
        2.3.1 Cryoablation for Cancer Industry Trends
        2.3.2 Cryoablation for Cancer Market Drivers
        2.3.3 Cryoablation for Cancer Market Challenges
        2.3.4 Cryoablation for Cancer Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cryoablation for Cancer Players by Revenue
        3.1.1 Global Top Cryoablation for Cancer Players by Revenue (2020-2025)
        3.1.2 Global Cryoablation for Cancer Revenue Market Share by Players (2020-2025)
    3.2 Global Cryoablation for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players Ranking by Cryoablation for Cancer Revenue
    3.4 Global Cryoablation for Cancer Market Concentration Ratio
        3.4.1 Global Cryoablation for Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cryoablation for Cancer Revenue in 2024
    3.5 Global Key Players of Cryoablation for Cancer Head office and Area Served
    3.6 Global Key Players of Cryoablation for Cancer, Product and Application
    3.7 Global Key Players of Cryoablation for Cancer, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cryoablation for Cancer Breakdown Data by Type
    4.1 Global Cryoablation for Cancer Historic Market Size by Type (2020-2025)
    4.2 Global Cryoablation for Cancer Forecasted Market Size by Type (2026-2031)

5 Cryoablation for Cancer Breakdown Data by Application
    5.1 Global Cryoablation for Cancer Historic Market Size by Application (2020-2025)
    5.2 Global Cryoablation for Cancer Forecasted Market Size by Application (2026-2031)

6 North America
    6.1 North America Cryoablation for Cancer Market Size (2020-2031)
    6.2 North America Cryoablation for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
    6.3 North America Cryoablation for Cancer Market Size by Country (2020-2025)
    6.4 North America Cryoablation for Cancer Market Size by Country (2026-2031)
    6.5 United States
    6.6 Canada

7 Europe
    7.1 Europe Cryoablation for Cancer Market Size (2020-2031)
    7.2 Europe Cryoablation for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
    7.3 Europe Cryoablation for Cancer Market Size by Country (2020-2025)
    7.4 Europe Cryoablation for Cancer Market Size by Country (2026-2031)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

8 Asia-Pacific
    8.1 Asia-Pacific Cryoablation for Cancer Market Size (2020-2031)
    8.2 Asia-Pacific Cryoablation for Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031
    8.3 Asia-Pacific Cryoablation for Cancer Market Size by Region (2020-2025)
    8.4 Asia-Pacific Cryoablation for Cancer Market Size by Region (2026-2031)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

9 Latin America
    9.1 Latin America Cryoablation for Cancer Market Size (2020-2031)
    9.2 Latin America Cryoablation for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
    9.3 Latin America Cryoablation for Cancer Market Size by Country (2020-2025)
    9.4 Latin America Cryoablation for Cancer Market Size by Country (2026-2031)
    9.5 Mexico
    9.6 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cryoablation for Cancer Market Size (2020-2031)
    10.2 Middle East & Africa Cryoablation for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031
    10.3 Middle East & Africa Cryoablation for Cancer Market Size by Country (2020-2025)
    10.4 Middle East & Africa Cryoablation for Cancer Market Size by Country (2026-2031)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

11 Key Players Profiles
    11.1 BTG International Ltd
        11.1.1 BTG International Ltd Company Details
        11.1.2 BTG International Ltd Business Overview
        11.1.3 BTG International Ltd Cryoablation for Cancer Introduction
        11.1.4 BTG International Ltd Revenue in Cryoablation for Cancer Business (2020-2025)
        11.1.5 BTG International Ltd Recent Development
    11.2 IceCure Medical
        11.2.1 IceCure Medical Company Details
        11.2.2 IceCure Medical Business Overview
        11.2.3 IceCure Medical Cryoablation for Cancer Introduction
        11.2.4 IceCure Medical Revenue in Cryoablation for Cancer Business (2020-2025)
        11.2.5 IceCure Medical Recent Development
    11.3 Adagio Medical
        11.3.1 Adagio Medical Company Details
        11.3.2 Adagio Medical Business Overview
        11.3.3 Adagio Medical Cryoablation for Cancer Introduction
        11.3.4 Adagio Medical Revenue in Cryoablation for Cancer Business (2020-2025)
        11.3.5 Adagio Medical Recent Development
    11.4 CooperSurgical
        11.4.1 CooperSurgical Company Details
        11.4.2 CooperSurgical Business Overview
        11.4.3 CooperSurgical Cryoablation for Cancer Introduction
        11.4.4 CooperSurgical Revenue in Cryoablation for Cancer Business (2020-2025)
        11.4.5 CooperSurgical Recent Development
    11.5 HOYA
        11.5.1 HOYA Company Details
        11.5.2 HOYA Business Overview
        11.5.3 HOYA Cryoablation for Cancer Introduction
        11.5.4 HOYA Revenue in Cryoablation for Cancer Business (2020-2025)
        11.5.5 HOYA Recent Development
    11.6 Medtronic
        11.6.1 Medtronic Company Details
        11.6.2 Medtronic Business Overview
        11.6.3 Medtronic Cryoablation for Cancer Introduction
        11.6.4 Medtronic Revenue in Cryoablation for Cancer Business (2020-2025)
        11.6.5 Medtronic Recent Development
    11.7 Boston Scientific
        11.7.1 Boston Scientific Company Details
        11.7.2 Boston Scientific Business Overview
        11.7.3 Boston Scientific Cryoablation for Cancer Introduction
        11.7.4 Boston Scientific Revenue in Cryoablation for Cancer Business (2020-2025)
        11.7.5 Boston Scientific Recent Development
    11.8 Sanarus Technologies
        11.8.1 Sanarus Technologies Company Details
        11.8.2 Sanarus Technologies Business Overview
        11.8.3 Sanarus Technologies Cryoablation for Cancer Introduction
        11.8.4 Sanarus Technologies Revenue in Cryoablation for Cancer Business (2020-2025)
        11.8.5 Sanarus Technologies Recent Development
    11.9 AtriCure
        11.9.1 AtriCure Company Details
        11.9.2 AtriCure Business Overview
        11.9.3 AtriCure Cryoablation for Cancer Introduction
        11.9.4 AtriCure Revenue in Cryoablation for Cancer Business (2020-2025)
        11.9.5 AtriCure Recent Development
    11.10 Cryofocus Biotech
        11.10.1 Cryofocus Biotech Company Details
        11.10.2 Cryofocus Biotech Business Overview
        11.10.3 Cryofocus Biotech Cryoablation for Cancer Introduction
        11.10.4 Cryofocus Biotech Revenue in Cryoablation for Cancer Business (2020-2025)
        11.10.5 Cryofocus Biotech Recent Development
    11.11 Endo International Plc
        11.11.1 Endo International Plc Company Details
        11.11.2 Endo International Plc Business Overview
        11.11.3 Endo International Plc Cryoablation for Cancer Introduction
        11.11.4 Endo International Plc Revenue in Cryoablation for Cancer Business (2020-2025)
        11.11.5 Endo International Plc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Cryoablation for Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cryoablation System
 Table 3. Key Players of Cyroablation Needles
 Table 4. Key Players of Cyroprobes
 Table 5. Key Players of Others
 Table 6. Global Cryoablation for Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cryoablation for Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Cryoablation for Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Cryoablation for Cancer Market Share by Region (2020-2025)
 Table 10. Global Cryoablation for Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Cryoablation for Cancer Market Share by Region (2026-2031)
 Table 12. Cryoablation for Cancer Market Trends
 Table 13. Cryoablation for Cancer Market Drivers
 Table 14. Cryoablation for Cancer Market Challenges
 Table 15. Cryoablation for Cancer Market Restraints
 Table 16. Global Cryoablation for Cancer Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Cryoablation for Cancer Market Share by Players (2020-2025)
 Table 18. Global Top Cryoablation for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryoablation for Cancer as of 2024)
 Table 19. Ranking of Global Top Cryoablation for Cancer Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Cryoablation for Cancer Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Cryoablation for Cancer, Headquarters and Area Served
 Table 22. Global Key Players of Cryoablation for Cancer, Product and Application
 Table 23. Global Key Players of Cryoablation for Cancer, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Cryoablation for Cancer Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Cryoablation for Cancer Revenue Market Share by Type (2020-2025)
 Table 27. Global Cryoablation for Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Cryoablation for Cancer Revenue Market Share by Type (2026-2031)
 Table 29. Global Cryoablation for Cancer Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Cryoablation for Cancer Revenue Market Share by Application (2020-2025)
 Table 31. Global Cryoablation for Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Cryoablation for Cancer Revenue Market Share by Application (2026-2031)
 Table 33. North America Cryoablation for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Cryoablation for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Cryoablation for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Cryoablation for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Cryoablation for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Cryoablation for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Cryoablation for Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Cryoablation for Cancer Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Cryoablation for Cancer Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Cryoablation for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Cryoablation for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cryoablation for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Cryoablation for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Cryoablation for Cancer Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Cryoablation for Cancer Market Size by Country (2026-2031) & (US$ Million)
 Table 48. BTG International Ltd Company Details
 Table 49. BTG International Ltd Business Overview
 Table 50. BTG International Ltd Cryoablation for Cancer Product
 Table 51. BTG International Ltd Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 52. BTG International Ltd Recent Development
 Table 53. IceCure Medical Company Details
 Table 54. IceCure Medical Business Overview
 Table 55. IceCure Medical Cryoablation for Cancer Product
 Table 56. IceCure Medical Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 57. IceCure Medical Recent Development
 Table 58. Adagio Medical Company Details
 Table 59. Adagio Medical Business Overview
 Table 60. Adagio Medical Cryoablation for Cancer Product
 Table 61. Adagio Medical Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 62. Adagio Medical Recent Development
 Table 63. CooperSurgical Company Details
 Table 64. CooperSurgical Business Overview
 Table 65. CooperSurgical Cryoablation for Cancer Product
 Table 66. CooperSurgical Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 67. CooperSurgical Recent Development
 Table 68. HOYA Company Details
 Table 69. HOYA Business Overview
 Table 70. HOYA Cryoablation for Cancer Product
 Table 71. HOYA Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 72. HOYA Recent Development
 Table 73. Medtronic Company Details
 Table 74. Medtronic Business Overview
 Table 75. Medtronic Cryoablation for Cancer Product
 Table 76. Medtronic Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 77. Medtronic Recent Development
 Table 78. Boston Scientific Company Details
 Table 79. Boston Scientific Business Overview
 Table 80. Boston Scientific Cryoablation for Cancer Product
 Table 81. Boston Scientific Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 82. Boston Scientific Recent Development
 Table 83. Sanarus Technologies Company Details
 Table 84. Sanarus Technologies Business Overview
 Table 85. Sanarus Technologies Cryoablation for Cancer Product
 Table 86. Sanarus Technologies Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 87. Sanarus Technologies Recent Development
 Table 88. AtriCure Company Details
 Table 89. AtriCure Business Overview
 Table 90. AtriCure Cryoablation for Cancer Product
 Table 91. AtriCure Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 92. AtriCure Recent Development
 Table 93. Cryofocus Biotech Company Details
 Table 94. Cryofocus Biotech Business Overview
 Table 95. Cryofocus Biotech Cryoablation for Cancer Product
 Table 96. Cryofocus Biotech Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 97. Cryofocus Biotech Recent Development
 Table 98. Endo International Plc Company Details
 Table 99. Endo International Plc Business Overview
 Table 100. Endo International Plc Cryoablation for Cancer Product
 Table 101. Endo International Plc Revenue in Cryoablation for Cancer Business (2020-2025) & (US$ Million)
 Table 102. Endo International Plc Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Cryoablation for Cancer Picture
 Figure 2. Global Cryoablation for Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cryoablation for Cancer Market Share by Type: 2024 VS 2031
 Figure 4. Cryoablation System Features
 Figure 5. Cyroablation Needles Features
 Figure 6. Cyroprobes Features
 Figure 7. Others Features
 Figure 8. Global Cryoablation for Cancer Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Cryoablation for Cancer Market Share by Application: 2024 VS 2031
 Figure 10. Hospitals Case Studies
 Figure 11. Specialty Clinics Case Studies
 Figure 12. Outpatient Surgery Center Case Studies
 Figure 13. Others Case Studies
 Figure 14. Cryoablation for Cancer Report Years Considered
 Figure 15. Global Cryoablation for Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Cryoablation for Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Cryoablation for Cancer Market Share by Region: 2024 VS 2031
 Figure 18. Global Cryoablation for Cancer Market Share by Players in 2024
 Figure 19. Global Top Cryoablation for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryoablation for Cancer as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Cryoablation for Cancer Revenue in 2024
 Figure 21. North America Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Cryoablation for Cancer Market Share by Country (2020-2031)
 Figure 23. United States Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Cryoablation for Cancer Market Share by Country (2020-2031)
 Figure 27. Germany Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Cryoablation for Cancer Market Share by Region (2020-2031)
 Figure 35. China Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Cryoablation for Cancer Market Share by Country (2020-2031)
 Figure 43. Mexico Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Cryoablation for Cancer Market Share by Country (2020-2031)
 Figure 47. Turkey Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Cryoablation for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. BTG International Ltd Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 51. IceCure Medical Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 52. Adagio Medical Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 53. CooperSurgical Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 54. HOYA Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 55. Medtronic Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 56. Boston Scientific Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 57. Sanarus Technologies Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 58. AtriCure Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 59. Cryofocus Biotech Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 60. Endo International Plc Revenue Growth Rate in Cryoablation for Cancer Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed

Description

The global market for Cryoablation for Cancer was valued at US$ 1136 million in the year 2024 and is projected to reach a revised size of US$ 1580 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Cryoablation is a novel treatment currently used to treat benign breast tumors (called fibroadenomas). Cryoablation is now being studied in patients with certain types of small breast cancer. The treatment places a small probe in the center of the cancer and subsequently uses liquid nitrogen to destroy breast cancer tumors by freezing them.In the treatment of fibroadenomas, cryoablation has proven less invasive and less likely to affect cosmetic appearance than surgery. It could be possible for breast cancer patients to enjoy the same benefits in the future.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cryoablation for Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Related Reports

Global Cryoablation for Cancer Market Research Report 2024
Cryoablation is a novel treatment currently used to treat benign breast tumors (called fibroadenomas). Cryoablation is now being studied in patients with certain types of small breast cancer. The treatment places a small probe in the center of the cancer and subsequently uses liquid nitrogen to destroy breast cancer tumors by freezing them.In the treatment of fibroadenomas, cryoablation has proven less invasive and less likely to affect cosmetic appearance than surgery. It could be possible for breast cancer patients to enjoy the same benefits in the future.
Published: 2024-02-05
Pages: 89
USD 2900.00
(Single User License)
Global Cryoablation for Cancer Market Insights, Forecast to 2030
Cryoablation is a novel treatment currently used to treat benign breast tumors (called fibroadenomas). Cryoablation is now being studied in patients with certain types of small breast cancer. The treatment places a small probe in the center of the cancer and subsequently uses liquid nitrogen to destroy breast cancer tumors by freezing them.In the treatment of fibroadenomas, cryoablation has proven less invasive and less likely to affect cosmetic appearance than surgery. It could be possible for breast cancer patients to enjoy the same benefits in the future.
Published: 2024-04-28
Pages: 105
USD 4900.00
(Single User License)
Cryoablation for Cancer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cryoablation for Cancer was estimated to be worth US$ 1136 million in 2024 and is forecast to a readjusted size of US$ 1580 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 104
USD 3950.00
(Single User License)
Global Cryoablation for Cancer Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cryoablation for Cancer market is projected to grow from US$ 1136 million in 2024 to US$ 1580 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 136
USD 4900.00
(Single User License)
Global Cryoablation for Cancer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cryoablation for Cancer market size was US$ 1136 million in 2024 and is forecast to a readjusted size of US$ 1580 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 95
USD 4250.00
(Single User License)
Global Cryoablation for Cancer Market Research Report 2026
The global Cryoablation for Cancer market was valued at US$ 1186 million in 2025 and is anticipated to reach US$ 1650 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 114
USD 2900.00
(Single User License)
Cryoablation for Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cryoablation for Cancer was estimated to be worth US$ 1186 million in 2025 and is projected to reach US$ 1650 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 116
USD 3950.00
(Single User License)

Global Cryoablation for Cancer Market Research Report 2024
Cryoablation is a novel treatment currently used to treat benign breast tumors (called fibroadenomas). Cryoablation is now being studied in patients with certain types of small breast cancer. The treatment places a small probe in the center of the cancer and subsequently uses liquid nitrogen to destroy breast cancer tumors by freezing them.In the treatment of fibroadenomas, cryoablation has proven less invasive and less likely to affect cosmetic appearance than surgery. It could be possible for breast cancer patients to enjoy the same benefits in the future.
Published: 2024-02-05
Pages: 89
USD 2900.00 (Single User License)
Global Cryoablation for Cancer Market Insights, Forecast to 2030
Cryoablation is a novel treatment currently used to treat benign breast tumors (called fibroadenomas). Cryoablation is now being studied in patients with certain types of small breast cancer. The treatment places a small probe in the center of the cancer and subsequently uses liquid nitrogen to destroy breast cancer tumors by freezing them.In the treatment of fibroadenomas, cryoablation has proven less invasive and less likely to affect cosmetic appearance than surgery. It could be possible for breast cancer patients to enjoy the same benefits in the future.
Published: 2024-04-28
Pages: 105
USD 4900.00 (Single User License)
Cryoablation for Cancer- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cryoablation for Cancer was estimated to be worth US$ 1136 million in 2024 and is forecast to a readjusted size of US$ 1580 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 104
USD 3950.00 (Single User License)
Global Cryoablation for Cancer Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cryoablation for Cancer market is projected to grow from US$ 1136 million in 2024 to US$ 1580 million by 2031, at a CAGR of 4.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-02
Pages: 136
USD 4900.00 (Single User License)
Global Cryoablation for Cancer Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cryoablation for Cancer market size was US$ 1136 million in 2024 and is forecast to a readjusted size of US$ 1580 million by 2031 with a CAGR of 4.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 95
USD 4250.00 (Single User License)
Global Cryoablation for Cancer Market Research Report 2026
The global Cryoablation for Cancer market was valued at US$ 1186 million in 2025 and is anticipated to reach US$ 1650 million by 2032, at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 114
USD 2900.00 (Single User License)
Cryoablation for Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cryoablation for Cancer was estimated to be worth US$ 1186 million in 2025 and is projected to reach US$ 1650 million, growing at a CAGR of 4.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 116
USD 3950.00 (Single User License)